The prediction value of combined serum levels of TMAO and TML for poor prognosis in patients with heart failure
10.3760/cma.j.cn112148-20240104-00008
- VernacularTitle:血清TMAO及TML水平联合预测心力衰竭患者不良预后
- Author:
Rui XI
1
;
Qin FAN
;
Rong TAO
Author Information
1. 上海交通大学医学院附属瑞金医院心脏科，上海 200025
- Keywords:
Heart failure;
Trimethylamine N-oxide;
Trimethyllysine;
Cardiovascular death;
Heart failure readmission
- From:
Chinese Journal of Cardiology
2024;52(4):405-412
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the predictive value of combined serum levels of trimethylamine N-oxide (TMAO) and trimethyllysine (TML) for poor prognosis in patients with heart failure.Methods:This single-center prospective cohort study included hospitalized patients with heart failure and complete baseline data from the Department of Cardiology at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from June 2017 to December 2020. Patients were categorized into four groups based on median serum levels of TMAO and TML after admission: TMAO low level TML low level group (TMAO<9.7 μmol/L, TML<0.73 μmol/L), TMAO low level TML high level group (TMAO<9.7 μmol/L, TML≥0.73 μmol/L), TMAO high level TML low level group (TMAO≥9.7 μmol/L, TML<0.73 μmol/L) and TMAO high level TML high level group (TMAO≥9.7 μmol/L, TML≥0.73 μmol/L). The primary endpoint was a composite endpoint of cardiovascular death and readmission for heart failure. Multiple factor Cox regression analysis was conducted to evaluate the correlation between serum TMAO and TML levels and poor prognosis in patients with heart failure.Results:A total of 471 patients with heart failure were included, with an mean age of (62.5±12.0) years and a median follow-up time of 1.61 (1.06, 2.90) years. Multivariate Cox regression analysis showed that after adjusting for age, gender, and traditional risk factors, the TMAO high level TML high level group had a higher incidence of primary endpoint events compared to the TMAO low level TML low level group ( HR=1.71, 95% CI 1.05-2.77, P=0.03). Conclusion:Elevated serum levels of both TMAO and TML can effectively predict the occurrence of long-term adverse events in patients with heart failure.
